Selective Internal Radiation Therapy Using Yttrium-90 Resin Microspheres for Patients With Primary RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
RESIRT: a phase 1 study of selective internal radiation therapy using yttrium-90 resin microspheres in patients with primary renal cell carcinoma
Clin Genitourin Cancer 2022 May 17;[EPub Ahead of Print], PL de Souza, P Aslan, W Clark, et alRenal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.